These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 13626505)

  • 1. [Dose-response relations of N-formyl-chitosan-polysulfuric acid ester (Ro 1-8307) in regard to the activation of the clearing factor & inhibition of coagulation in comparison with heparin in animal experiments & in man].
    REBER K; STUDER A; TOBLER R; KOLLER F
    Acta Haematol; 1959 Jan; 21(1):31-5. PubMed ID: 13626505
    [No Abstract]   [Full Text] [Related]  

  • 2. Demonstration of antiparacoagulating activity of acid mucopolysaccharides and extracts of the aortic wall.
    Lipiński B
    Thromb Diath Haemorrh; 1969 Nov; 22(2):401-2. PubMed ID: 4245335
    [No Abstract]   [Full Text] [Related]  

  • 3. Anticoagulant properties of three mucopolysaccharides used in rheumatology.
    Bauer F; Schulz P; Reber G; Bouvier CA
    Thromb Haemost; 1983 Oct; 50(3):652-5. PubMed ID: 6228031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of heparin on blood lipolytic and coagulation activity in patients with hypertensive disease].
    Oleĭnik NI
    Klin Med (Mosk); 1969 Jul; 47(7):75-9. PubMed ID: 5385094
    [No Abstract]   [Full Text] [Related]  

  • 5. [Studies on the coagulation effect of mucopolysaccharides from the human aorta].
    Józsa L; Szabó Z; Lusztig G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1966; 86(3):345-59. PubMed ID: 4167669
    [No Abstract]   [Full Text] [Related]  

  • 6. A comparison of biological activities and chemical analyses for various heparin preparations.
    Jaques LB; Kavanagh L; Lavallée A
    Arzneimittelforschung; 1967 Jun; 17(6):774-8. PubMed ID: 4234593
    [No Abstract]   [Full Text] [Related]  

  • 7. [Indicators of blood coagulation and serum lipids after food loading and heparin administration].
    Malanowicz W; Zambrowicz K; Tenenbaum B
    Pol Arch Med Wewn; 1968; 40(5):591-8. PubMed ID: 5661499
    [No Abstract]   [Full Text] [Related]  

  • 8. The influence of a heparin-like compound on hypertension, electrolytes and aldosterone in man.
    Abbott EC; Gornall AG; Sutherland DJ; Laidlaw JC; Stiefel M
    Can Med Assoc J; 1966 May; 94(22):1155-64. PubMed ID: 4222823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects on platelets and on the clotting system of four glycosaminoglycans extracted from hog mucosa and one extracted from aortic intima of the calf.
    Cella G; Scattolo N; Luzzatto G; Stevanato F; Vio C; Girolami A
    J Med; 1986; 17(5-6):331-46. PubMed ID: 2953835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutralization of the anticoagulant effects of glycosaminoglycans by serum amyloid P component: comparison with other plasma and platelet proteins.
    Williams EC; Huppert BJ; Asakura S
    J Lab Clin Med; 1992 Jul; 120(1):159-67. PubMed ID: 1377216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The relation between the physicochemical structure and the anticoagulant effects of polysulfated chitosan derivatives].
    Drozd NN; Sher AI; Makarov VA; Gal'braĭkh LS; Vikhoreva GA; Gorbacheva IN
    Eksp Klin Farmakol; 1994; 57(4):42-5. PubMed ID: 7950784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clearing and anti-platelet-aggregation effects of a heparinoid of natural origin].
    Marini U; Bastoni F; Gibelli A
    Clin Ter; 1974 Oct; 71(1):13-31. PubMed ID: 4138995
    [No Abstract]   [Full Text] [Related]  

  • 13. [Mechanisms of anticoagulant effect of chitosan sulfuric acid ester].
    Drozd NN; Bashkov GV; Makarov VA; Kheĭlomskiĭ AB; Gorbacheva IN
    Vopr Med Khim; 1992; 38(5):12-4. PubMed ID: 1492385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Heparin: chemico-pharmacological characteristics].
    Ferrari L; Boffi C
    Farmaco Prat; 1975 Oct; 30(10):461-77. PubMed ID: 1104374
    [No Abstract]   [Full Text] [Related]  

  • 15. Anticoagulant activity of galactosaminoglucuronoglycan: a pharmacological study.
    Matera M; Scalia S
    Drugs Exp Clin Res; 1991; 17(1):65-73. PubMed ID: 1833172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morning vs evening effects of intrapulmonary administration of heparin in healthy men.
    Markiewicz A; Tausz B; Zahorska-Markiewicz B; Nawrot J
    Int J Clin Pharmacol Ther Toxicol; 1992 Oct; 30(10):400-4. PubMed ID: 1446957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Considerations on the changes of the coagulation and fibrinolytic picture and of uricemia during therapy with heparin in low doses. Relations with the change of the lipemic level].
    Lombardi V; Bonini M
    Minerva Med; 1970 Oct; 61(87):4889-92. PubMed ID: 5488539
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of acetaldehyde-glycosaminoglycan mixtures upon Factor IXa and Factor IX-Deficient Plasma.
    Brecher AS; Moon AR; Gray KD
    Alcohol; 2006 Jun; 39(2):97-104. PubMed ID: 17134662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of the thromboelastograph for registration of the time of euglobulin lysis in normal rats and those with experimentally modified fibrinolysis].
    Prino G; Mantovani M; Butti A
    Farmaco Prat; 1969 Sep; 24(9):552-61. PubMed ID: 4187112
    [No Abstract]   [Full Text] [Related]  

  • 20. The effects of glycosaminoglycans on coagulation: a thromboelastographic study.
    Senzolo M; Coppell J; Cholongitas E; Riddell A; Triantos CK; Perry D; Burroughs AK
    Blood Coagul Fibrinolysis; 2007 Apr; 18(3):227-36. PubMed ID: 17413758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.